Infection prophylaxis in antirheumatic therapy: emphasis on vaccination.
To assess data concerning vaccination among persons with rheumatic diseases, focusing on the effects of immune-modulating therapeutic agents on the responses. Patients with rheumatic diseases receiving certain therapeutic agents may exhibit less robust responses to vaccination. However, data in various studies are conflicting. In general, even in studies demonstrating attenuation of vaccine response, increases in titers are observed and may be protective. Vaccinations are an important strategy to prevent infections. Although antirheumatic therapies may affect responses, patients should still be considered candidates for all appropriate vaccinations.